Back to search

Peptide record

TPDB64934

MVIIA-c Blood-Brain Barrier standard
38 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB64934
MVIIA-c
Blood-Brain Barrier
Delivery and barrier-penetrating peptides
BBPpredict
standard
No
A 38-aa standard natural blood-brain barrier peptide sequence curated from BBPpredict, with an available 3D structural model.
C-terminal: TAT-transducing domain was fused at C-terminal
Sequence
CKGKGAKCSRLMYDCCTGSCRSGKCGGYGRKKRRQRRR
Physicochemical Analysis
C170H299N69O48S7
NEHIFPWV
R
4302.10
10.85
14
1
5
+13
10.55
-1.379
12.89
Mammalian: 1.2 hour Yeast: >20 hour E.coli: >10 hour
3355
77.99
13
Residue Composition
number
1
A
8
R
0
N
1
D
6
C
0
E
1
Q
7
G
0
H
0
I
1
L
6
K
1
M
0
F
0
P
3
S
1
T
0
W
2
Y
0
V
Amino Acid Distribution
A: 1 R: 8 N: 0 D: 1 C: 6 E: 0 Q: 1 G: 7 H: 0 I: 0 L: 1 K: 6 M: 1 F: 0 P: 0 S: 3 T: 1 W: 0 Y: 2 V: 0
Chemical Descriptors
38
C170H299N69O48S7
4302.10
10.85
+13
10.55
-1.379
TAT-transducing domain was fused at C-terminal
Linear
Similarity
Cationic
CysLysGlyLysGlyAlaLysCysSerArgLeuMetTyrAspCysCysThrGlySerCysArgSerGlyLysCysGlyGlyTyrGlyArgLysLysArgArgGlnArgArgArg
N[C@@]([H])(CS)C(=O)N[C@@]([H])(CCCCN)C(=O)NCC(=O)N[C@@]([H])(CCCCN)C(=O)NCC(=O)N[C@@]([H])(C)C(=O)N[C@@]([H])(CCCCN)C(=O)N[C@@]([H])(CS)C(=O)N[C@@]([H])(CO)C(=O)N[C@@]([H])(CCCNC(=N)N)C(=O)N[C@@]([H])(CC(C)C)C(=O)N[C@@]([H])(CCSC)C(=O)N[C@@]([H])(Cc1ccc(O)cc1)C(=O)N[C@@]([H])(CC(=O)O)C(=O)N[C@@]([H])(CS)C(=O)N[C@@]([H])(CS)C(=O)N[C@@]([H])([C@]([H])(O)C)C(=O)NCC(=O)N[C@@]([H])(CO)C(=O)N[C@@]([H])(CS)C(=O)N[C@@]([H])(CCCNC(=N)N)C(=O)N[C@@]([H])(CO)C(=O)NCC(=O)N[C@@]([H])(CCCCN)C(=O)N[C@@]([H])(CS)C(=O)NCC(=O)NCC(=O)N[C@@]([H])(Cc1ccc(O)cc1)C(=O)NCC(=O)N[C@@]([H])(CCCNC(=N)N)C(=O)N[C@@]([H])(CCCCN)C(=O)N[C@@]([H])(CCCCN)C(=O)N[C@@]([H])(CCCNC(=N)N)C(=O)N[C@@]([H])(CCCNC(=N)N)C(=O)N[C@@]([H])(CCC(=O)N)C(=O)N[C@@]([H])(CCCNC(=N)N)C(=O)N[C@@]([H])(CCCNC(=N)N)C(=O)N[C@@]([H])(CCCNC(=N)N)C(=O)O
Evidence Records 1 records
Evidence 1 Activity

Activity

Blood-Brain Barrier
0.237 micromolar

Target

HEK293 cells

Assay & Model

Acetic Acid-Induced WRITHING test
Inhibitory activity toward N-type calcium channels, albeit with a slightly reduced endothelialcacy i
Origin/Source
Tremor Symptom Test
Ii did not induce tremor symptoms.
MIC

Source & Reference

NA
B3Pdb

Other

Intranasal and Intervenous
It showed that C-terminal fusion with TAT peptide render its BBB penetration capacity, without signi
Receptor-mediated transcytosis
Combined with TAT protein
Additional Detail Fields 1 fields
Intranasal and Intervenous